Purple Biotech Ltd.
PPBT | NASDAQ
$1.21
+$0.06 (+5.22%)
Nov 2, 2026, 11:20 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 500K |
Cost of Revenue | n/a | n/a | n/a | 40K | 40K | 40K | 40K | 48.52K | 48.52K | 48.52K | 48.52K | 49.88K | 49.88K | 49.88K | 49.88K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | -40K | -40K | -40K | -40K | -48.52K | -48.52K | -48.52K | -48.52K | -49.88K | -49.88K | -49.88K | -49.88K | n/a | n/a | n/a | n/a | -1.06M | -1.06M | -558K |
Operating Income | -28.36M | -28.3M | -27.45M | -5.03M | -5.79M | -8.01M | -11.07M | -16.39M | -20.01M | -21.68M | -22.34M | -22.59M | -21.92M | -13.2M | -15.41M | -40.24M | -38.2M | -38.17M | -37.5M | 15.61M | 14.5M | 8.72M |
Interest Income | 222K | 216K | 250K | 709.63K | 716.63K | 764.63K | 805.63K | 346K | 924K | 926K | 1.11M | 1.62M | 1.16M | 1.13M | 908.77K | 449K | 269K | 258K | 300K | 336.5K | 361K | 317.5K |
Pretax Income | -24.6M | -26.13M | -26.49M | -3.27M | -2.63M | -3.95M | -7.28M | -11.78M | -16.16M | -18.91M | -20.03M | -21.15M | -20.94M | -19.33M | -21.75M | -20.18M | -18.33M | -18.42M | -17.67M | -13.97M | -11.1M | -21.36M |
Net Income | -24.49M | -26.02M | -26.39M | -3.25M | -2.61M | -3.93M | -7.24M | -11.71M | -16.08M | -18.82M | -19.93M | -21.05M | -20.84M | -19.23M | -21.65M | -20.73M | -19.04M | -19.13M | -18.38M | -13.42M | -10.4M | -20.66M |
Selling & General & Admin | 3.27M | 3.36M | 2.98M | 2.42M | 2.42M | 2.61M | 3M | 3.68M | 4.05M | 4.62M | 5.2M | 5.94M | 6.4M | 6.47M | 6.23M | 5.72M | 5.53M | 5.56M | 5.84M | 6.39M | 6.93M | 6.48M |
Research & Development | 4.35M | 4.2M | 3.73M | 2.36M | 3.12M | 4.96M | 7.62M | 12.46M | 15.7M | 17.02M | 17.09M | 16.6M | 15.48M | 13.85M | 16.31M | 14.44M | 12.6M | 12.6M | 11.66M | 10.64M | 11.2M | 10.68M |
Other Expenses | 20.74M | 20.74M | 20.74M | 208K | 208K | 410K | 410K | 202K | 202K | n/a | n/a | 1 | 1 | -7.18M | -7.18M | 20.07M | 20.07M | 20.01M | 20.01M | -32.64M | -32.62M | -25.38M |
Operating Expenses | 28.36M | 28.3M | 27.45M | 4.99M | 5.75M | 7.97M | 11.03M | 16.34M | 19.96M | 21.63M | 22.29M | 22.54M | 21.87M | 13.15M | 15.36M | 40.24M | 38.2M | 38.17M | 37.5M | -15.61M | -14.5M | -8.22M |
Interest Expense | 68K | 59K | 63K | 40K | 546K | 570K | 552K | 2.55M | 2.05M | 2.17M | 2.22M | 223K | 223K | 126K | 108K | 108K | 113K | 164K | 123K | 123K | 102K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.66M | 1.66M | 1.66M | 1.66M |
Cost & Expenses | 28.36M | 28.3M | 27.45M | 5.03M | 5.79M | 8.01M | 11.07M | 16.39M | 20.01M | 21.68M | 22.34M | 22.59M | 21.92M | 13.2M | 15.41M | 40.24M | 38.2M | 38.17M | 37.5M | -15.61M | -14.5M | -8.22M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 10.86M | 9.35M | 11.91M | 4.56M | 2.74M | 2.63M | 2.05M | 1.73M | 1.38M | 1.36M | 1.28M | 1.09M | 1.05M | 991.95K | 919.48K | 903.68K | 899.1K | 890.64K | 1.02M | 875.62K | 876.03K | 868.88K |
Shares Outstanding (Diluted) | 10.86M | 9.31M | 11.91M | 4.56M | 2.74M | 2.63M | 2.05M | 1.73M | 1.38M | 1.36M | 1.29M | 1.09M | 1.05M | 991.93K | 919.46K | 903.67K | 899.09K | 890.63K | 877.01K | 875.61K | 876.51K | 868.86K |
EPS (Basic) | -2.22 | -2.66 | -2.84 | -1.06 | -1.16 | -2.50 | -5.10 | -8.64 | -12.88 | -16.04 | -18.18 | -20 | -22 | -20 | -24 | -22 | -20 | -20 | -20 | -7.36 | 30 | -11.64 |
EPS (Diluted) | -2.22 | -2.66 | -2.84 | -1.06 | -1.16 | -2.50 | -5.10 | -8.68 | -12.92 | -16.08 | -18.22 | -20 | -22 | -20 | -24 | -24 | -22 | -22 | -22 | -7.36 | 30 | -11.64 |
EBITDA | -24.28M | -25.84M | -26.23M | -3.55M | -2.41M | -3.71M | -7.05M | -12.45M | -17.33M | -19.95M | -21.03M | -21.28M | -21.08M | -19.57M | -21.99M | -19.93M | -18.05M | -18.09M | -17.53M | -17.63M | -18.9M | -17.52M |
EBIT | -24.53M | -26.07M | -26.43M | -3.74M | -2.59M | -3.9M | -7.24M | -12.65M | -17.53M | -20.15M | -21.23M | -21.48M | -21.27M | -19.76M | -22.19M | -20.14M | -18.28M | -18.32M | -17.71M | -17.95M | -19.11M | -17.71M |
Depreciation & Amortization | 246K | 223K | 203K | 190K | 181K | 183K | 186K | 194.52K | 195.52K | 199.52K | 197.52K | 198.88K | 195.88K | 195.88K | 200.88K | 212K | 228K | 236K | 185.5K | 312.5K | 204.5K | 189.5K |
Add to Watchlist
Select watchlists to add or remove PPBT